A new meta-analysis comparing depression treatments finds that control groups in psilocybin trials show less improvement than ...

The battle against depression just got an unexpected ally from nature, and it’s making researchers rethink everything they know about mental health treatment. With 280 million people worldwide ...

The decision will allow patients with treatment-resistant depression to receive psilocybin therapy in strictly controlled ...

Three versions of synthetic psilocybin have received the US Food and Drug Administration’s “breakthrough therapy” designation — in 2018 for treatment-resistant depression, which is ...

Research indicates two doses of psychedelic compound may rival six weeks of conventional treatment By Serena Summer Feb 23, 2025 11:30 am Photo credit: Shutterstock.com / PeopleImages.com - Yuri A ...

In Switzerland, the medical use of LSD, MDMA, and psilocybin was permitted since 2014 for both research and the treatment of mental disorders. Some states in the United States advanced in the ...

Cancer patients can experience depression so severe that it affects their ability to go through treatment. Psilocybin, a chemical in some mushrooms that causes psychedelic effects, has been linked ...

As U.S. News reported, if approved by the FDA, psilocybin could be used to treat depression, with an estimated 5.1 to 5.6 million Americans potentially benefiting from the therapy.